Yasin Ragai
Dr. Yasin Ragai is the Assistant Head of the Egyptian Drug Authority, known for his active role in monitoring and evaluating pharmaceuticals for safety and efficacy. He has recently been in the news for overseeing the decision to halt the registration of drugs containing Obeticholic Acid due to concerns over their risk-benefit balance, emphasizing the importance of patient safety and the need for effective medication.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Egypt | 1 | 8.00 | 0.05% | +0% | 102,334,404 | 52,533 | $303,000 | 156$ |
| Totals | 1 | 102,334,404 | 52,533 | $303,000 | 156$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Egypt:
Dr. Yasin Ragai, Assistant Head of the Egyptian Drug Authority, announced the withdrawal of nearly 341,000 expired units of medication.
8
Egypt:
Yasin Ragai is the Assistant Head of the Egyptian Drug Authority and is involved in overseeing drug production and distribution.
8
Egypt:
Dr. Yasin Ragai, Assistant Head of the Drug Authority, explained the details of the decision regarding expired medications.
8
Egypt:
Dr. Yasin Ragai, Assistant Head of the Drug Authority, stated that the authority continuously monitors reports from global drug agencies.
7